1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

35 Suppliers, 10 USDMF, 7 CEP/COS, 7 JDMF, 4 EU WC, 5 KDMF, 5 NDC API, 19 Listed Suppliers

DEVELOPMENTS

34 Drug(s) in Development

34 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

4 Suppliers

4 Suppliers

DOSSIERs // Finished Dosage Forms

566 Dossiers, 60 FDA Orange Book, 275 Europe, 3 Canada, 18 Australia, 83 South Africa, 127 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML), SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

Suppliers, 35 BASF, 32 Kerry, 30 Roquette, 15 Microlex e.U, 14 Gangwal Chemicals, 13 Seppic, 12 Sigachi Industries, 12 Actylis, 11 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 SPI Pharma, 5 Nanjing Well Pharmaceutical, 4 Kima Chemical, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 4 Ingredion Pharma Solutions, 4 Ulanqab Kema New Material, 4 Vasa Pharmachem, 3 The Dow Chemical Company, 3 DKSH, 2 Rochem International Inc, 2 Seqens, 2 Finar, 2 Nanjing Bold Chemical, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 1 Qualicaps, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 BioSpectra, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Clariant, 1 Pfanstiehl, 1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 55 Coating Systems & Additives, 43 Disintegrants & Superdisintegrants, 39 Direct Compression, 34 Controlled & Modified Release, 31 Solubilizers, 31 Thickeners and Stabilizers, 31 Granulation, 23 Parenteral, 20 Lubricants & Glidants, 19 Topical, 18 Film Formers & Plasticizers, 17 Taste Masking, 14 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 6 Emulsifying Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 268 Finished Drug Prices

MARKET PLACE

65 APIs, 38 DOSSIERS // FDF

PATENTS

9 US Patents, 8 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 3 EDQM Standards, 2 USP Standards, 10 Other Ref. Standards

DIGITAL CONTENT

8 Data Compilation & Company Tracker #PharmaFlow, 53 News

Annual Sales of 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

35 Suppliers

10 USDMF

7 CEP/COS

7 JDMF

4 EU WC

5 KDMF

5 NDC API

19 Listed Suppliers

DEVELOPMENTS

34 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

4 Suppliers

DOSSIERs // Finished Dosage Forms

566 Dossiers

60 FDA Orange Book

275 Europe

3 Canada

18 Australia

83 South Africa

127 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML)

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

Suppliers

35 BASF

32 Kerry

30 Roquette

15 Microlex e.U

14 Gangwal Chemicals

13 Seppic

12 Sigachi Industries

12 Actylis

11 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 DFE Pharma

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 SPI Pharma

5 Nanjing Well Pharmaceutical

4 Kima Chemical

4 Pharmatrans-Sanaq

4 Prachin Chemical

4 Ingredion Pharma Solutions

4 Ulanqab Kema New Material

4 Vasa Pharmachem

3 The Dow Chemical Company

3 DKSH

2 Rochem International Inc

2 Seqens

2 Finar

2 Nanjing Bold Chemical

2 Jai Radhe Sales

2 Nomisma Healthcare

1 Qualicaps

1 Aeon Procare

1 Qianhao Chemical (Hebei) Co., Ltd

1 BioSpectra

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

1 Clariant

1 Pfanstiehl

1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

INJECTABLE;INJECTION - 200MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 400MG/200ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons